Moolec Science Statistics
Total Valuation
Moolec Science has a market cap or net worth of $14.35 million.
| Market Cap | 14.35M |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Tuesday, September 8, 2026, before market open.
| Earnings Date | Sep 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Moolec Science has 2.08 million shares outstanding.
| Current Share Class | 2.08M |
| Shares Outstanding | 2.08M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 0.03% |
| Float | 573,192 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 3.46 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -28.64% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 2.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.33% in the last 52 weeks. The beta is -0.32, so Moolec Science's price volatility has been lower than the market average.
| Beta (5Y) | -0.32 |
| 52-Week Price Change | -70.33% |
| 50-Day Moving Average | 7.37 |
| 200-Day Moving Average | 7.60 |
| Relative Strength Index (RSI) | 45.34 |
| Average Volume (20 Days) | 7,389 |
Short Selling Information
The latest short interest is 4,512, so 0.22% of the outstanding shares have been sold short.
| Short Interest | 4,512 |
| Short Previous Month | 9,414 |
| Short % of Shares Out | 0.22% |
| Short % of Float | 0.79% |
| Short Ratio (days to cover) | 0.38 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Pretax Income | n/a |
| Net Income | n/a |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -$5.70 million and capital expenditures -$402,063, giving a free cash flow of -$6.10 million.
| Operating Cash Flow | -5.70M |
| Capital Expenditures | -402,063 |
| Depreciation & Amortization | 1.07M |
| Net Borrowing | 4.79M |
| Free Cash Flow | -6.10M |
| FCF Per Share | -$2.93 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Moolec Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.44% |
| Shareholder Yield | -1.44% |
| Earnings Yield | n/a |
| FCF Yield | -43.05% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 141.14% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 5, 2026. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jan 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |